180 related articles for article (PubMed ID: 37540498)
1. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract][Full Text] [Related]
2. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
3. Circulating inflammation markers and risk of epithelial ovarian cancer.
Clendenen TV; Lundin E; Zeleniuch-Jacquotte A; Koenig KL; Berrino F; Lukanova A; Lokshin AE; Idahl A; Ohlson N; Hallmans G; Krogh V; Sieri S; Muti P; Marrangoni A; Nolen BM; Liu M; Shore RE; Arslan AA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):799-810. PubMed ID: 21467242
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative.
Brasky TM; Kabat GC; Ho GYF; Thomson CA; Nicholson WK; Barrington WE; Bittoni MA; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2018 Sep; 29(9):855-862. PubMed ID: 30046933
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
6. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
7. Serum C-reactive protein and risk of lung cancer: a case-control study.
Xu M; Zhu M; Du Y; Yan B; Wang Q; Wang C; Zhao J
Med Oncol; 2013 Mar; 30(1):319. PubMed ID: 23254959
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
9. Circulating inflammation markers and prospective risk for lung cancer.
Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein and risk of lung cancer.
Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).
Lundin E; Dossus L; Clendenen T; Krogh V; Grankvist K; Wulff M; Sieri S; Arslan AA; Lenner P; Berrino F; Hallmans G; Zeleniuch-Jacquotte A; Toniolo P; Lukanova A
Cancer Causes Control; 2009 Sep; 20(7):1151-9. PubMed ID: 19301134
[TBL] [Abstract][Full Text] [Related]
15. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
Faber DR; van der Graaf Y; Westerink J; Visseren FL
Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
[TBL] [Abstract][Full Text] [Related]
16. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
17. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study.
Toriola AT; Grankvist K; Agborsangaya CB; Lukanova A; Lehtinen M; Surcel HM
Ann Oncol; 2011 Aug; 22(8):1916-21. PubMed ID: 21292643
[TBL] [Abstract][Full Text] [Related]
18. Weight Gain and the Risk of Ovarian Cancer in
Kim SJ; Lubinski J; Huzarski T; Møller P; Armel S; Karlan BY; Senter L; Eisen A; Foulkes WD; Singer CF; Tung N; Bordeleau L; Neuhausen SL; Olopade OI; Eng C; Weitzel JN; Fruscio R; Narod SA; Kotsopoulos J;
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2038-2043. PubMed ID: 34426412
[TBL] [Abstract][Full Text] [Related]
19. Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies.
Peres LC; Townsend MK; Birmann BM; Conejo-Garcia JR; Kim Y; Kubzansky LD; Magpantay LI; Martinez-Maza O; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):710-718. PubMed ID: 33563649
[TBL] [Abstract][Full Text] [Related]
20. Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.
Schildkraut JM
Am J Epidemiol; 2020 Jul; 189(7):671-673. PubMed ID: 31845738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
